LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $651,105 | +4.4% | 9,693,368 | +7.3% | 0.10% | +9.2% |
| Q2 2023 | $623,434 | +1083.8% | 9,031,324 | +726.9% | 0.09% | +987.5% |
| Q1 2023 | $52,665 | +61.2% | 1,092,149 | +66.9% | 0.01% | +60.0% |
| Q4 2022 | $32,674 | -99.9% | 654,519 | -0.2% | 0.01% | +25.0% |
| Q3 2022 | $26,757,000 | -14.2% | 655,798 | +15.6% | 0.00% | 0.0% |
| Q2 2022 | $31,194,000 | +765.3% | 567,155 | +356.5% | 0.00% | – |
| Q1 2021 | $3,605,000 | -77.9% | 124,229 | -78.6% | 0.00% | -100.0% |
| Q4 2020 | $16,327,000 | -9.7% | 579,777 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $18,075,000 | -50.0% | 585,508 | -31.0% | 0.00% | -60.0% |
| Q2 2020 | $36,134,000 | – | 849,017 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |